These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7565004

  • 1. [Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
    Marlier S, Carsuzaa F, De Jaureguiberry JP, Galzin M, Carloz E, Carli P, Chagnon A.
    Med Trop (Mars); 1995; 55(2):182. PubMed ID: 7565004
    [No Abstract] [Full Text] [Related]

  • 2. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R, Pai VV, Shroff HJ, Gandewar K.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract] [Full Text] [Related]

  • 3. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B.
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract] [Full Text] [Related]

  • 4. A rare variant of erythema nodosum leprosum: a case report.
    Dave S, Thappa DM, Nori AV, Jayanthi S.
    Dermatol Online J; 2003 Dec; 9(5):11. PubMed ID: 14996384
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM, Reis AC, De Rezende TM, Borges AS, Ferreira MS, Nishioka SA.
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A case of histoid leprosy responding to ofloxacin along with standard MDT.
    Vora NS, Vora VN, Mukhopadhyay AK, Roy K, Patel NN, Ghosh A.
    Indian J Lepr; 1995 Jun; 67(2):183-6. PubMed ID: 8537707
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM, Ibanez MA.
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K, Thappa DM, Kadhiravan T.
    Indian J Lepr; 2001 Apr; 73(2):167-9. PubMed ID: 11579653
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB, Cavalcanti Neto PF, Martelli CM, Stefani MM, Maceira JP, Gomes MK, Schettini AP, Rebello PF, Pignataro PE, Ueda ES, Narahashi K, Scollard DM.
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.